Angiotensin Receptor Blockers Market

Angiotensin II receptor blockers (ARBs), also known as angiotensin II receptor antagonists, AT1 receptor antagonists or sartans, are a group of pharmaceuticals that modulate the renin?angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.
Angiotensin Receptor Blockers Market aims to provide a comprehensive presentation of the global market for Angiotensin Receptor Blockers (ARBs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiotensin Receptor Blockers (ARBs). Angiotensin Receptor Blockers Market contains market size and forecasts of Angiotensin Receptor Blockers (ARBs) in global, including the following market information:
Global Angiotensin Receptor Blockers (ARBs) Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Angiotensin Receptor Blockers (ARBs) Market Sales, 2018-2023, 2024-2030, (K MT)
Global top five Angiotensin Receptor Blockers (ARBs) companies in 2022 (%)
The global Angiotensin Receptor Blockers (ARBs) market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Valsartan Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Angiotensin Receptor Blockers (ARBs) include Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb and Bayer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Angiotensin Receptor Blockers (ARBs) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Angiotensin Receptor Blockers (ARBs) Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K MT)
Global Angiotensin Receptor Blockers (ARBs) Market Segment Percentages, by Type, 2022 (%)
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan
Global Angiotensin Receptor Blockers (ARBs) Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K MT)
Global Angiotensin Receptor Blockers (ARBs) Market Segment Percentages, by Application, 2022 (%)
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other
Global Angiotensin Receptor Blockers (ARBs) Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K MT)
Global Angiotensin Receptor Blockers (ARBs) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Angiotensin Receptor Blockers (ARBs) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Angiotensin Receptor Blockers (ARBs) revenues share in global market, 2022 (%)
Key companies Angiotensin Receptor Blockers (ARBs) sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Angiotensin Receptor Blockers (ARBs) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Angiotensin Receptor Blockers (ARBs), market overview.
Chapter 2: Global Angiotensin Receptor Blockers (ARBs) market size in revenue and volume.
Chapter 3: Detailed analysis of Angiotensin Receptor Blockers (ARBs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Angiotensin Receptor Blockers (ARBs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Angiotensin Receptor Blockers (ARBs) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.